The Russian Health Ministry has registered the nasal version of its vaccine against coronavirus – Sputnik V. It is the world’s first nasal vaccine against COVID-19.

The Russian news agency TASS in January reported that the nasal vaccine against the novel coronavirus infection will be in civil circulation and available for Russians within 3-4 months, quoting the director of the Gamaleya Centre, Alexander Gintsburg. The Gamalaya Centre, a research institute, is the manufacturer of Sputnik V.

In October 2021, the Russian health ministry authorized the second phase clinical trials of the coronavirus vaccine in the nasal spray form.

“Laboratory tests show the Sputnik V protects against Omicron in its ordinary injection form, and it will certainly be efficient in the nasal form,” Gintsburg told TASS.

The Sputnik V coronavirus vaccine was administered first in India in Hyderabad in May 2021. The first consignment of imported doses of the Sputnik V vaccine landed in India on May 1, and received regulatory clearance from the Central Drugs Laboratory on May 13, 2021.

The Sputnik-V vaccine was developed by researchers at Gamaleya National Research Centre for Epidemiology and Microbiology in Moscow.

According to indiatoday